BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8917738)

  • 1. Intravenous immunoglobulin therapy.
    Chapel H
    QJM; 1996 Sep; 89(9):641-3. PubMed ID: 8917738
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of intravenous immunoglobulins in pediatric diseases.
    Ramasubramanian KV; Kumar A; Kabra SK; Seth V
    Indian Pediatr; 1999 Jan; 36(1):51-63. PubMed ID: 10709123
    [No Abstract]   [Full Text] [Related]  

  • 3. [Polyvalent immunoglobins in general pediatrics: what place, what risk, and what cost?].
    Dommergues JP; Bader-Meunier B
    Arch Pediatr; 1999; 6 Suppl 2():397s-399s. PubMed ID: 10370548
    [No Abstract]   [Full Text] [Related]  

  • 4. Current treatment of neuromuscular diseases.
    Kokontis L; Gutmann L
    Arch Neurol; 2000 Jul; 57(7):939-43. PubMed ID: 10891975
    [No Abstract]   [Full Text] [Related]  

  • 5. IVIg in myasthenia gravis, Lambert Eaton myasthenic syndrome and inflammatory myopathies: current status.
    Illa I
    J Neurol; 2005 May; 252 Suppl 1():I14-8. PubMed ID: 15959667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment for Lambert-Eaton myasthenic syndrome.
    Maddison P; Newsom-Davis J
    Cochrane Database Syst Rev; 2003; (2):CD003279. PubMed ID: 12804456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and electrophysiologic improvement in Lambert-Eaton syndrome with intravenous immunoglobulin therapy.
    Bird SJ
    Neurology; 1992 Jul; 42(7):1422-3. PubMed ID: 1620360
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemolysis after high-dose intravenous Ig.
    Thomas MJ; Misbah SA; Chapel HM; Jones M; Elrington G; Newsom-Davis J
    Blood; 1993 Dec; 82(12):3789. PubMed ID: 8260715
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term follow-up of Lambert-Eaton syndrome treated with intravenous immunoglobulin.
    Muchnik S; Losavio AS; Vidal A; Cura L; Mazia C
    Muscle Nerve; 1997 Jun; 20(6):674-8. PubMed ID: 9149073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of subacute paraneoplastic cerebellar syndrome with intravenous immunoglobulin.
    Counsell CE; McLeod M; Grant R
    Neurology; 1994 Jun; 44(6):1184-5. PubMed ID: 8208425
    [No Abstract]   [Full Text] [Related]  

  • 11. [Is intravenous administration of immunoglobulins a first-choice method in autoimmune diseases?].
    Vermeulen M
    Ned Tijdschr Geneeskd; 1993 Sep; 137(39):1955-8. PubMed ID: 8413702
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of intravenous immunoglobulin in Lambert-Eaton myasthenic syndrome with small-cell lung cancer: correlation with the titer of anti-voltage-gated calcium channel antibody.
    Takano H; Tanaka M; Koike R; Nagai H; Arakawa M; Tsuji S
    Muscle Nerve; 1994 Sep; 17(9):1073-5. PubMed ID: 8065398
    [No Abstract]   [Full Text] [Related]  

  • 13. Lambert-Eaton (myasthenic) syndrome: pre-anaesthetic treatment with intravenous immunoglobulins.
    Biarnés A; Rochera MI
    Anaesthesia; 1996 Aug; 51(8):797. PubMed ID: 8795338
    [No Abstract]   [Full Text] [Related]  

  • 14. [Polyvalent intravenous immunoglobulins: their use in dermatology].
    Derancourt C; Humbert P; Agache P
    Ann Dermatol Venereol; 1992; 119(6-7):487-8. PubMed ID: 1444110
    [No Abstract]   [Full Text] [Related]  

  • 15. Use of intravenous immunoglobulin in Lambert-Eaton myasthenic syndrome.
    Peterlin BL; Flood W; Kothari MJ
    J Am Osteopath Assoc; 2002 Dec; 102(12):682-4. PubMed ID: 12501987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intravenously administered immunoglobulin first-choice remedy in autoimmune diseases?].
    Breems DA; de Haas PW; Visscher F; Sabbe LJ; Busch HF; van Doorn PA
    Ned Tijdschr Geneeskd; 1993 Nov; 137(45):2336. PubMed ID: 8255343
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapy in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
    Newsom-Davis J
    Semin Neurol; 2003 Jun; 23(2):191-8. PubMed ID: 12894384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immune globulin use in children. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
    CMAJ; 1992 Jan; 146(2):121-4. PubMed ID: 1735037
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe dyshidrotic eczema after intravenous immunoglobulin therapy for Kawasaki syndrome.
    Shiraishi T; Yamamoto T
    Pediatr Dermatol; 2013; 30(3):e30-1. PubMed ID: 22304420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risks and benefits of intravenous immunoglobulin treatment in children.
    Fasano MB
    Curr Opin Pediatr; 1995 Dec; 7(6):688-94. PubMed ID: 8776020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.